H-1B sponsorship profile: Atilar Pharma Corporation. Across U.S. Department of Labor LCA disclosures, Atilar Pharma Corporation filed 2 Labor Condition Applications covering 8 H-1B worker positions between fiscal year 2024 and fiscal year 2024. The employer’s DOL certification rate sits at 50% (1 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Atilar Pharma Corporation’s H-1B petitions range from $44,000 at the low end to $50,000 at the high end, with a petition-weighted average of $47,000. That range reflects the mix of occupations the company sponsors, led by Finished Goods Supervisor (2 petitions at $47,000 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Atilar Pharma Corporation is headquartered in Houston, TX under NAICS code 32541, and places H-1B workers across 1 state, most heavily in TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.